Clinical Oncology

Papers
(The H4-Index of Clinical Oncology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Survival Outcomes for p16-positive Oropharyngeal Squamous Cell Carcinoma Based on Human Papillomavirus Status96
Assessing the Tolerability of Adjuvant and Neoadjuvant Chemotherapy in the Treatment of Early and Locally Advanced Breast Cancer in the Elderly Population at a UK Tertiary Cancer Centre85
RCR Meetings50
RCR Meetings48
Localised Synovial Sarcoma in Adolescents and Young Adults Versus Adults – Is There a Difference in Outcome?43
Dosimetry in the Prediction and Reduction of Acute Skin Toxicity from the Use of Brass Bolus in Postmastectomy Chest Wall Radiotherapy Treatment42
OncoFlash–Research Updates in a Flash! (December 2022)42
Instant Oncology: Impower13341
OncoFlash – Research Updates in a Flash! (June 2022)41
Audit of cabozantinib outcomes for metastatic renal cell carcinoma at Norfolk and Norwich University Hospital37
An educational initiative to develop radiotherapy-specific teaching following the introduction of the oncology common stem year35
Contact X-ray brachytherapy (CXB) for early rectal cancer: A review of outcomes from a single UK centre35
Improving Palliative Radiotherapy Training: A Multi-professional, Combined Clinical and Training Improvement Project32
The First Use of Stereotactic Ablative Body Radiotherapy (SABR) in Extra-cranial Non-lung Oligometastatic Disease: A Single Centre32
Ayrshire Men Diagnosed with Locally Advanced Prostate Cancer between 2012 and 2013; How do they do?30
The Time has Come to Say Goodbye30
What can the Interventional Endoscopist Offer in the Management of Upper Gastrointestinal Malignancies?30
Switching to a Fixed-dose Combined Pertuzumab and Trastuzumab With Recombinant Human Hyaluronidase Subcutaneous Injection to Treat Human Epidermal Growth Factor Receptor 2-positive Breast Cancer in Re28
OncoFlash: Research Updates in a Flash!27
The “real” outcome of esophageal cancer in elderly.27
Current Management Practices for Endometrial Cancer (EC) in the UK: A National Healthcare Professional Survey (KNOW-EC)27
Dose-Painting Proton Radiotherapy Guided by Functional MRI in Non-enhancing High-Grade Gliomas26
Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer26
Perspectives of Healthcare Professionals on the Management and Treatment of Advanced Ovarian Cancer in the UK: Results From the KNOW-OC Survey25
Clinical Relevance of Immunohistochemical Subtypes in Early-Stage, Lymph Node-negative Breast Cancer. Results of a Large Cohort Study24
Dose Accumulation for Pelvic Stereotactic Ablative Body Radiotherapy Reirradiation. In Regard to Slevin et al.24
0.088953018188477